Rosalind Advisors, Inc. Top Holdings and 13F Report (2026) About Rosalind Advisors, Inc.Investment ActivityRosalind Advisors, Inc. has $311.88 million in total holdings as of September 30, 2026.Rosalind Advisors, Inc. owns shares of 46 different stocks, but just 14 companies or ETFs make up 80% of its holdings.Approximately 16.21% of the portfolio was purchased this quarter.About 9.40% of the portfolio was sold this quarter.This quarter, Rosalind Advisors, Inc. has purchased 35 new stocks and bought additional shares in 10 stocks.Rosalind Advisors, Inc. sold shares of 9 stocks and completely divested from 5 stocks this quarter.Largest Holdings Delcath Systems $52,707,212Verastem $34,103,897Adherex Technologies $33,952,211Xeris Biopharma $24,690,105CYBIN INC $17,058,139 Largest New Holdings this Quarter 76029N106 - Replimune Group $13,240,000 Holding74365U107 - Protara Therapeutics $7,320,000 Holding77313F106 - Rocket Pharmaceuticals $5,786,000 Holding00509G209 - Acumen Pharmaceuticals $2,442,000 Holding31447E204 - FEMASYS INC $1,639,900 Holding Largest Purchases this Quarter Replimune Group 1,000,000 shares (about $13.24M)Aquestive Therapeutics 1,750,000 shares (about $8.10M)Protara Therapeutics 2,400,000 shares (about $7.32M)Rocket Pharmaceuticals 2,200,000 shares (about $5.79M)PepGen 1,650,000 shares (about $3.99M) Largest Sales this Quarter CYBIN INC 568,845 shares (about $6.99M)Atea Pharmaceuticals 790,489 shares (about $4.12M)Xeris Biopharma 326,334 shares (about $3.12M)Vaxcyte 50,639 shares (about $2.88M)TALPHERA INC 1,035,357 shares (about $1.20M) Sector Allocation Over TimeMap of 500 Largest Holdings ofRosalind Advisors, Inc. Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorDCTHDelcath Systems$52,707,2120.0%3,300,38916.9%HealthcareVSTMVerastem$34,103,897$2,012,500 ▲6.3%4,236,50910.9%HealthcareFENCAdherex Technologies$33,952,2110.0%3,188,00110.9%HealthcareXERSXeris Biopharma$24,690,105$3,119,753 ▼-11.2%2,582,6477.9%HealthcareCYBIN INC$17,058,139$6,991,105 ▼-29.1%1,387,9695.5%COM NEWSVRASavara$16,399,1040.0%3,178,1215.3%HealthcareREPLReplimune Group$13,240,000$13,240,000 ▲New Holding1,000,0004.2%HealthcareVOR BIOPHARMA INC$11,623,517$751,771 ▼-6.1%609,1993.7%COM NEWMDWDMediWound$10,314,4740.0%749,0543.3%HealthcareX4 PHARMACEUTICALS INC$9,322,8210.0%3,214,7663.0%COM NEWAQSTAquestive Therapeutics$9,260,000$8,102,500 ▲700.0%2,000,0003.0%HealthcarePCVXVaxcyte$8,498,641$2,881,359 ▼-25.3%149,3612.7%HealthcareTARAProtara Therapeutics$7,320,000$7,320,000 ▲New Holding2,400,0002.3%HealthcareMYOMyomo$6,111,902$436,800 ▲7.7%3,917,8862.0%HealthcareBCRXBioCryst Pharmaceuticals$6,010,1280.0%721,5041.9%HealthcareRCKTRocket Pharmaceuticals$5,786,000$5,786,000 ▲New Holding2,200,0001.9%HealthcarePEPGPepGen$4,840,000$3,993,000 ▲471.4%2,000,0001.6%HealthcarePROFProfound Medical$4,803,0840.0%828,1181.5%HealthcareTALPHERA INC$4,795,607$1,201,014 ▼-20.0%4,134,1441.5%COM NEWNEURAXIS INC$4,039,667$295,301 ▲7.9%548,1231.3%COMOVIDOvid Therapeutics$2,758,9050.0%1,107,9940.9%HealthcareNSPRInspireMD$2,616,8480.0%3,905,7430.8%HealthcareABOSAcumen Pharmaceuticals$2,442,000$2,442,000 ▲New Holding1,100,0000.8%HealthcareEYPTEyepoint Pharmaceuticals$2,275,845$955,667 ▼-29.6%695,9770.7%HealthcareABIVAX SA$2,066,4480.0%20,8690.7%SPONSORED ADSBIOFRONTERA INC$1,932,431$554,773 ▲40.3%1,789,2880.6%COM NEWFEMASYS INC$1,639,900$1,639,900 ▲New Holding759,2130.5%COM NEWAVIRAtea Pharmaceuticals$1,459,118$4,118,448 ▼-73.8%280,0610.5%HealthcareCG ONCOLOGY INC$1,417,800$1,417,800 ▲New Holding20,0000.5%COMSPRUCE BIOSCIENCES INC$1,288,196$316,596 ▲32.6%26,5170.4%COM NEWREGENTIS BIOMATERIALS LTD$1,270,0500.0%701,6850.4%ORDINARY SHARESKURAKura Oncology$1,071,0000.0%100,0000.3%HealthcareGRACE THERAPEUTICS INC$1,023,808$1,023,808 ▲New Holding476,1900.3%COMPOLYPID LTD$932,848$1,119,580 ▼-54.5%177,0110.3%COMSPDR SERIES TRUST$925,000$404,780 ▲77.8%250,0000.3%PUTSTATE STR SPDR S&P 500 ETF T$382,000$382,000 ▲New Holding100,0000.1%PUTVERASTEM INC$356,535$356,535 ▲New Holding293,6000.1%CALLINVESCO QQQ TR$257,500$257,500 ▲New Holding50,0000.1%PUTPEPGEN INC$256,880$256,880 ▲New Holding412,7000.1%CALLONKURE THERAPEUTICS INC$183,954$224,796 ▼-55.0%67,5060.1%COM CL AXERIS BIOPHARMA HOLDINGS INC$160,000$160,000 ▲New Holding400,0000.1%CALLSELLAS LIFE SCIENCES GROUP INC$127,000$10,282 ▲8.8%618,8000.0%PUTBRISTOL-MYERS SQUIBB CO$84,200$84,200 ▲New Holding20,0000.0%CALLEYEPOINT INC$50,000$46,416 ▲1,295.0%701,7000.0%CALLCORCEPT THERAPEUTICS INC$23,500$23,500 ▲New Holding10,0000.0%PUTCELLDEX THERAPEUTICS INC$0New Holding128,8000.0%PUTCLDXCelldex Therapeutics$0$7,442,000 ▼-100.0%00.0%HealthcareCG ONCOLOGY INC$0$375,100 ▼-100.0%00.0%CALLISHARES TR$0$110,000 ▼-100.0%00.0%PUTTENAX THERAPEUTICS INC$0$13,950 ▼-100.0%00.0%PUTShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.